Molecular Docking and Spectroscopic Study on the Interaction of Serum Albumin with Iron(iii) Diamine Sarcophagine
- 7 January 2015
- journal article
- Published by CSIRO Publishing in Australian Journal of Chemistry
- Vol. 68 (6) , 999-1010
Abstract
Iron(iii) diamine sarcophagine (DiAmsar) has attracted great attention in biological and medical applications. In particular, for any potential in vivo application, knowledge about the interaction of iron(iii) DiAmsar with serum albumin is crucial. As a step towards the elucidation of the fate of iron(iii) DiAmsar introduced into an organism, first, iron(iii) DiAmsar was synthesised and characterised. In the next step, interactions of iron(iii) DiAmsar with human serum albumin (HSA) and bovine serum albumin (BSA) were systematically investigated by various spectroscopic methods (Fourier-transform infrared, UV-visible, fluorescence) and cyclic voltammetry and molecular docking techniques under simulated physiological conditions. The fluorescence intensities of HSA and BSA decreased remarkably with increasing concentration of iron(iii) DiAmsar. The Stern–Volmer quenching constant KSV at different temperatures and corresponding thermodynamic parameters such as ΔHo, ΔGo, and ΔSo were calculated. The binding distance of iron(iii) DiAmsar with HSA and BSA was also determined using the theory of fluorescence energy transfer. Further, the conformational changes of HSA and BSA induced by iron(iii) DiAmsar were analysed by means of Fourier-transform (FT)-IR. In addition, molecular docking was performed to explore the possible binding sites and the microenvironment conditions around the bound iron(iii) DiAmsar.Keywords
This publication has 32 references indexed in Scilit:
- A method for the making and utility of gadolinium-labeled albumin microbubblesMagnetic Resonance Imaging, 2012
- The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for 64Cu RadiopharmaceuticalsTheranostics, 2012
- Layer-by-layer capsules for magnetic resonance imaging and drug deliveryAdvanced Drug Delivery Reviews, 2011
- In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate CancerJournal of Nuclear Medicine, 2011
- An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticalsNuclear Medicine and Biology, 2010
- Oxidative dehydrogenation of an amine group of a macrocyclic ligand in the coordination sphere of a CuII complexDalton Transactions, 2009
- 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activityNuclear Medicine and Biology, 2009
- Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64 Cu-SarAr immunoconjugatesProceedings of the National Academy of Sciences, 2007
- Bioreductive activation and drug chaperoning in cobalt pharmaceuticalsDalton Transactions, 2007
- A Functionalised Macrobicycle Complex Available for Surface Immobilisation and Protein GraftingBulletin of the Korean Chemical Society, 2007